Generalized Convulsions- a rare Presentation of HaNDL Syndrome |Biomedgrid
Journal: American Journal of Biomedical Science & Research (Vol.10, No. 2)Publication Date: 2020-08-27
Authors : Geetanjali S Rathore;
Page : 100-102
Keywords : HaNDL Syndrome; Lymphocytosis; Migraine; Convulsion; Transient neurological deficit; Stroke mimics;
Abstract
Headache with Neurologic Deficits and cerebrospinal fluid Lymphocytosis (HaNDL) syndrome is a rare entity related to migrainous headaches. It is a benign, self-limited disorder, which is characterized by transient neurological symptoms and cerebrospinal fluid lymphocytosis. The International Headache Society criteria requires, episodes involve migraine-like headache along with weakness, sensory changes, and/or aphasia lasting at least 4 hours. The cerebrospinal fluid is notably abnormal, with an elevated protein and lymphocyte count greater than 15 cells/μL. Episodes typically recur but resolve without long-term sequalae. The most frequent neurologic signs are hemiparesis, hemisensory disturbances, and aphasia. Electroencephalogram (EEG) studies have shown that patients with HaNDL may have non-specific non-epileptiform changes such as asymmetrical generalized slowing, intermittent rhythmic delta activity and triphasic waves on their EEG. On our literature review, there are no reports of convulsive seizures that have been reported as a symptom of HaNDL. Our patient met the diagnostic criteria of HaNDL but had a unique neurological symptom of convulsive seizures.
Other Latest Articles
- Hyperventilation-Apnoea Syndrome in a 79-year Old Woman with Congestive Heart Failure |Biomedgrid
- Delivering Health and Care in the Digital Era depends on Forging New Partnerships |Biomedgrid
- Managing Mental Health Problems of Students During the Pandemic of COVID-19 |Biomedgrid
- A Review of the Impact of COVID-19 on Emergency Departments: Decrease in ED Visits Throughout the Pandemic |Biomedgrid
- In Silico Analysis of Baicalin’s Binding on Amyloid- β, Presenilin-1 and Tau Proteins: Validation in a Mouse Model of Cerebral Amyloidosis |Biomedgrid
Last modified: 2023-06-23 21:45:11